These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Crystal growth formation in melt extrudates. Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578 [TBL] [Abstract][Full Text] [Related]
4. The manufacture and characterisation of hot-melt extruded enteric tablets. Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604 [TBL] [Abstract][Full Text] [Related]
5. Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid. Bruce LD; Shah NH; Malick AW; Infeld MH; McGinity JW Eur J Pharm Biopharm; 2005 Jan; 59(1):85-97. PubMed ID: 15567305 [TBL] [Abstract][Full Text] [Related]
6. The use of agar as a novel filler for monolithic matrices produced using hot melt extrusion. Lyons JG; Devine DM; Kennedy JE; Geever LM; O'Sullivan P; Higginbotham CL Eur J Pharm Biopharm; 2006 Aug; 64(1):75-81. PubMed ID: 16697170 [TBL] [Abstract][Full Text] [Related]
7. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion. Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612 [TBL] [Abstract][Full Text] [Related]
8. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process. Young CR; Koleng JJ; McGinity JW J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545 [TBL] [Abstract][Full Text] [Related]
9. Citric acid as a solid-state plasticizer for Eudragit RS PO. Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259 [TBL] [Abstract][Full Text] [Related]
10. Plasticizing effect of ibuprofen induced an alteration of drug released from Kollidon SR matrices produced by direct compression. Wiranidchapong C; Ruangpayungsak N; Suwattanasuk P; Shuwisitkul D; Tanvichien S Drug Dev Ind Pharm; 2015 Jun; 41(6):1037-46. PubMed ID: 24918171 [TBL] [Abstract][Full Text] [Related]
11. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms. Zhu Y; Mehta KA; McGinity JW Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839 [TBL] [Abstract][Full Text] [Related]
12. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME. Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416 [TBL] [Abstract][Full Text] [Related]
13. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers. Maniruzzaman M; Rana MM; Boateng JS; Mitchell JC; Douroumis D Drug Dev Ind Pharm; 2013 Feb; 39(2):218-27. PubMed ID: 22452601 [TBL] [Abstract][Full Text] [Related]
14. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability. Ghebremeskel AN; Vemavarapu C; Lodaya M Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659 [TBL] [Abstract][Full Text] [Related]